Mylan

Mylan to acquire Agila to create global injectables platform

Thursday, February 28, 2013 03:19 PM

Pittsburgh-based Mylan has signed a definitive agreement to acquire Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6 billion in cash.

More... »

Biocon, Mylan enhance partnership with insulin products collaboration

Friday, February 15, 2013 11:45 AM

Biocon, a biotechnology company based in India, has formed a strategic collaboration with Mylan, a global pharmaceutical company, for for the global development and commercialization of generic versions of its three insulin analog products.

More... »

Pfizer, Mylan ink exclusive long-term collaboration for generics in Japan

Thursday, August 23, 2012 02:02 PM

Global research-based pharmaceutical company Pfizer and Canonsburg, Penn.-based pharmaceutical company Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan.

More... »

FDA approves first generic Actos to treat type 2 diabetes

Friday, August 17, 2012 02:33 PM

The FDA has approved the first generic version of Actos (pioglitazone hydrochloride) tablets, used in conjunction with diet and exercise to improve blood glucose control in adults with type 2 diabetes. Mylan Pharmaceuticals, based in Morgantown, W.V., gained FDA approval for 15mg, 30mg and 45mg pioglitazone tablets.

More... »

Gilead collaborates with Indian partners to reduce costs, improve availability of antiretroviral therapy

Thursday, August 2, 2012 02:44 PM

Pharmaceutical companies Gilead Sciences, Mylan Laboratories, Ranbaxy Laboratories and Strides Arcolab have entered into agreements to collaborate on promoting access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine (FTC) in developing countries, including single tablet regimens containing emtricitabine and fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines.

More... »

Mylan expands in Ireland, creates 500 jobs

Wednesday, April 18, 2012 02:54 PM

Mylan, a generics and specialty pharmaceutical company based in Canonsburg, Penn., will expand its operations in Dublin and Galway, Ireland, by investing up to $100 million over the next five years.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Mylan names president of Dey Pharma

Monday, December 12, 2011 01:50 PM

Mylan has named John Thievon president of Dey Pharma, Mylan's pharmaceutical business.

More... »

Teva: Doctors being contacted for trial of Copaxone copy

Wednesday, March 9, 2011 01:34 PM

Doctors are being contacted to organize a clinical trial for a copy of Teva Pharmaceutical’s multiple sclerosis medicine Copaxone, according to a report in FiercePharma.

More... »